Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation
Maya Ghoussaini(Regeneron (United States)), Carl Blomqvist(University of Helsinki), Patrick Neven(KU Leuven), Dylan M. Glubb(QIMR Berghofer Medical Research Institute), Emiel J. Rutgers(Oncode Institute), Fergus J. Couch(Mayo Clinic), Jenny Chang‐Claude(Universität Hamburg), Annegien Broeks, Joe Dennis(University of Cambridge), Mikael Eriksson(Herlev Hospital), Kamila Czene(Karolinska Institutet), Kyriaki Michailidou(Cyprus Institute of Neurology and Genetics), Ed Dicks(Institute of Cancer Research), Hans Wildiers(KU Leuven), Silje Nord(Oslo University Hospital), Robert Luben(University of Cambridge), Heli Nevanlinna(University of Helsinki), Celine M. Vachon(Leiden University Medical Center), Kinjal Desai(Hospital for Sick Children), Susanne Kaufmann(QIMR Berghofer Medical Research Institute), Dieter Flesch‐Janys, Petra Seibold(German Cancer Research Center), Siddhartha Kar(University of Cambridge), Mitul Shah(University of Cambridge), Stig E. Bojesen(University of Copenhagen), Anja Rudolph(Institut für Qualität im Management (Germany)), Diether Lambrechts(VIB-KU Leuven Center for Cancer Biology), Børge G. Nordestgaard(Gentofte Hospital), Daniel Klevebring(Karolinska Institutet), Bernard Thienpont(Center for Human Genetics), Richard Cowper‐Sal·lari(University Health Network), Stacey L. Edwards(Queensland University of Technology), Janet E. Olson(Cornell University), Taru Muranen(Karolinska Institutet), Qin Wang(University of Cambridge), Qi Guo(Medical University of South Carolina), Judith Brown(Cancer Research UK), Emily Hallberg(University of Kansas Medical Center), Kristiina Aittomäki(University of Helsinki), Hatef Darabi, Laura J. van’t Veer(University of California, San Francisco), Sune F. Nielsen(Herlev Hospital), Lorna J. Gibson(London School of Hygiene & Tropical Medicine), Julian Peto(University of Helsinki), Henrik Flyger(Herlev Hospital), Manjeet K. Bolla(University of Cambridge), Kristine M. Hillman(The University of Queensland), Isabel dos‐Santos‐Silva(London School of Hygiene & Tropical Medicine), Jonathan Beesley(QIMR Berghofer Medical Research Institute), Marjanka K. Schmidt(University of Cambridge)
Cited by 123
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Patterns of somatic mutation in human cancer genomes
|Nature|2007|3.1k